In vitro study reveals broad antibacterial and cytotoxic actions across bacterial and cell lines, suggesting potential applications as multifunctional therapeutics.
We report one greenish, blue‐colored Cu(II) complex, [Cu(pyz)(NO 3 ) 2 ] n 1 , using a solvent‐assisted technique with Cu(NO 3 ) 2 ·3H 2 O and pyrazine (pyz) in MeOH + DCM + ACN (1:1:1 M) (DCM = Dichloromethane, ACN = Acetonitrile). Spectroscopy, HRMS, SEM‐EDX, and XPS structurally characterize 1 . The primary research objectives focused on x‐ray structure, DFT integration using basis set B3LYP/LanL2DZ and B3LYP/6‐31+G (d, p), FMO, MEP, molecular docking, ADME/T, and biological activity exploration. X‐ray study delineated that 1 crystallizes in the orthorhombic space group Pmna , in which the crystal unit contains one Cu(II), two pyz, and two NO 3 – . The Cu(II) center adopted a distorted octahedral geometry, where H‐bonding interactions solely hold the supramolecular synthons. Hirshfeld surface accounts H···O (50.9%), N···Cu (3.2%), and H···N, H···C(π) (4.9%) contributions. TD‐DFT rationalizes the complex optical electronic transition with (%) HOMO–LUMO contributions. Additionally, 1 and pyz showed remarkable dose‐dependent antibacterial efficacy and in vitro cytotoxicity against Gram‐negative ( E. coli / P. aeruginosa) and Gram‐positive ( S. aureus / B. subtilis ) bacterial strains, including cell lines HepG2 and H9c2. The biological potency is substantiated by SAR (structure–activity relationships) and DFT outcomes. These complexes are significant to researchers because they serve as a model platform for quantum magnetism, potent biological agents, and function as electrochemical sensors in materials science.
No takes yet. Share an insight, caveat, or question.
Barman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: